Search Results - "Crouzet, S."

Refine Results
  1. 1

    Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram by Yates, D R, Hupertan, V, Colin, P, Ouzzane, A, Descazeaud, A, Long, J A, Pignot, G, Crouzet, S, Rozet, F, Neuzillet, Y, Soulie, M, Bodin, T, Valeri, A, Cussenot, O, Rouprêt, M

    Published in British journal of cancer (13-03-2012)
    “…Background: Owing to the scarcity of upper urinary tract urothelial carcinoma (UUT-UC) it is often necessary for investigators to pool data. A patient-specific…”
    Get full text
    Journal Article
  2. 2

    One-year Functional Outcomes after Holmium Laser Enucleation of the Prostate (HoLEP): Introduction of a Composite Score (Hexafecta) by Michaud, C, Codas-Duarte, R, Matillon, X, Crouzet, S, Badet, L, Fassi-Fehri, H

    Published in Progrès en urologie (Paris) (01-03-2022)
    “…To compare the efficiency (micturition symptoms, continence, erection) and safety of Holmium Laser Enucleation of the Prostate (HoLEP) with a single composite…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Candidates to salvage therapy after external-beam radiotherapy of prostate cancer: Predictors of local recurrence volume and metastasis-free survival by Maoui, M., Gonindard-Melodelima, C., Chapet, O., Colombel, M., Ruffion, A., Crouzet, S., Rouvière, O.

    Published in Diagnostic and interventional imaging (01-02-2021)
    “…•Initial Gleason score influences metastasis-free survival (MFS) of patients referred for salvage therapy of radio-recurrent prostate cancer.•Recurrent tumors…”
    Get full text
    Journal Article
  5. 5

    Value of prostate multiparametric magnetic resonance imaging for predicting biopsy results in first or repeat biopsy by Habchi, H, Bratan, F, Paye, A, Pagnoux, G, Sanzalone, T, Mège-Lechevallier, F, Crouzet, S, Colombel, M, Rabilloud, M, Rouvière, O

    Published in Clinical radiology (01-03-2014)
    “…Aim To assess multiparametric magnetic resonance imaging (mp-MRI) in predicting prostate biopsy results. Materials and methods Patients who underwent mp-MRI…”
    Get full text
    Journal Article
  6. 6

    Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted? by Alonzo, F, Melodelima, C, Bratan, F, Vitry, T, Crouzet, S, Gelet, A, Rouvière, O

    Published in Diagnostic and interventional imaging (01-04-2016)
    “…Abstract Objective The goal of this study was to assess the added value of dynamic contrast-enhanced (DCE) imaging in detecting locally radio-recurrent…”
    Get full text
    Journal Article
  7. 7

    Focal HIFU vs robot-assisted total prostatectomy: Functionnal and oncologic outcomes at one year by Arnouil, N, Gelet, A, Matillon, X, Rouviere, O, Colombel, M, Ruffion, A, Mège-Lechevallier, F, Subtil, F, Badet, L, Crouzet, S

    Published in Progrès en urologie (Paris) (01-10-2018)
    “…To analyse the functional and oncologic outcomes at one year of focal therapy with HIFU compared with total prostatectomy in patients with localised prostate…”
    Get more information
    Journal Article
  8. 8

    Variability induced by the MR imager in dynamic contrast-enhanced imaging of the prostate by Brunelle, S., Zemmour, C., Bratan, F., Mège-Lechevallier, F., Ruffion, A., Colombel, M., Crouzet, S., Sarran, A., Rouvière, O.

    Published in Diagnostic and interventional imaging (01-04-2018)
    “…To evaluate the variability induced by the imager in discriminating high-grade (Gleason≥7) prostate cancers (HGC) using dynamic contrast-enhanced MRI. We…”
    Get full text
    Journal Article
  9. 9

    Choice of new drugs in castration-resistant prostate cancer: predictive factors and effectiveness assessment by Basset, V, Flamand, V, Crouzet, S, Ploussard, G

    Published in Progrès en urologie (Paris) (01-10-2013)
    “…Docetaxel has been the cornerstone in the treatment of castration- resistant prostate cancer (CRPC) since 2004. The recent and almost simultaneous arrival of…”
    Get more information
    Journal Article
  10. 10

    Evolution of the number of incident cases of prostate cancer in France from 2001 to 2012 from 5 hospital centers by Helfrich, O, Crouzet, S, Ruffion, A, Houlgatte, A, Cavillon, C, Gerard, C, Villers, A

    Published in Progrès en urologie (Paris) (01-03-2015)
    “…The main objective is the study of the evolution of the number of incident cases of prostate cancer in France from 2001 to 2012 from 5 hospital centers of…”
    Get more information
    Journal Article
  11. 11

    Cryotherapy percutaneous for renal tumors: Our center's beginning experience by Lalloué, F, Ruffion, A, Valette, P-J, Crouzet, S, Martin, X, Rouvière, O, Paparel, P

    Published in Progrès en urologie (Paris) (01-04-2016)
    “…To evaluate oncologic and functional outcomes after percutaneous cryoablation (PCA) for renal masses based on our single center experience. We retrospectively…”
    Get more information
    Journal Article
  12. 12

    The W-shaped ileal neobladder: Long term functional outcomes and health-related quality of life by Belot, P-Y, Fassi-Fehri, H, Colombel, M, Matillon, X, Crouzet, S, Martin, X, Abid, N, Badet, L

    Published in Progrès en urologie (Paris) (01-05-2016)
    “…To evaluate functional outcomes and patients' health-related quality of life over ten years after a W-shaped ileal neobladder urinary diversion. From 1994 to…”
    Get more information
    Journal Article
  13. 13

    Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry by Blana, A, Robertson, C N, Brown, S C W, Chaussy, C, Crouzet, S, Gelet, A, Conti, G N, Ganzer, R, Pasticier, G, Thuroff, S, Ward, J F

    Published in Prostate cancer and prostatic diseases (01-09-2012)
    “…Background: To analyze data on patients with localized prostate cancer who were treated with complete high-intensity focused ultrasound (HIFU) prospectively…”
    Get full text
    Journal Article
  14. 14

    Mechanisms of resistance to CYP17A1 inhibitors in castrate resistant prostate cancer by Ripert, T, Crouzet, S, Ploussard, G, De La Taille, A, Robert, G

    Published in Progrès en urologie (Paris) (01-10-2013)
    “…Abiraterone acetate has increased the overall survival of patients with metastatic castration-resistant prostate cancer. However, despite an initial response…”
    Get more information
    Journal Article
  15. 15

    Treatment of stress urinary incontinence after prostate surgery: results of the artificial urinary sphincter after suburethral sling failure by Belot, P-Y, Fassi-Fehri, H, Crouzet, S, Codas, R, Badet, L, Gelet, A, Martin, X

    Published in Progrès en urologie (Paris) (01-10-2012)
    “…To determine whether the presence of a previously implanted suburethral sling for post-prostatic surgery incontinence influences the outcomes of subsequent AUS…”
    Get more information
    Journal Article
  16. 16

    Partial versus radical nephrectomy for renal cell carcinoma involving peri renal fat. Oncological and functional outcomes by Polo, G, Crouzet, S, Poissonnier, L, Roux, A, Deculier, E, Martin, X, Badet, L

    Published in Progrès en urologie (Paris) (01-06-2012)
    “…In the latest guidelines of the European Association of Urology, partial nephrectomy was a reference standard in tumors less than 7cm confined to the kidney…”
    Get more information
    Journal Article
  17. 17

    Single-port in urology by Crouzet, S, Haber, G-P, Kaouk, J

    Published in Progrès en urologie (Paris) (01-10-2010)
    “…Single-port transumbilical laparoscopy has emerged as an attempt to further enhance cosmetic benefits and reduce morbidity of minimally invasive surgery…”
    Get more information
    Journal Article
  18. 18

    Outcomes of HIFU for localised prostate cancer using the Ablatherm Integrate Imaging® device by Crouzet, S, Poissonnier, L, Murat, F-J, Pasticier, G, Rouvière, O, Mège-Lechevallier, F, Chapelon, J-Y, Martin, X, Gelet, A

    Published in Progrès en urologie (Paris) (01-03-2011)
    “…To report the functional and oncological outcomes of HIFU for prostate cancer using the Ablatherm Integrate Imaging(®) device. Between January 2005 and June…”
    Get more information
    Journal Article
  19. 19
  20. 20

    HIFU for prostate cancer in patients with a history of severe colorectal disease by Mitach, A, Crouzet, S, Poissonier, L, Rouvière, O, Mege-Lechevallier, F, Colombel, M, Martin, X, Gelet, A

    Published in Progrès en urologie (Paris) (01-10-2011)
    “…To report the functional and oncological outcomes of HIFU for prostate cancer in patients with a history of severe colorectal disease. Between 2002 and 2009,…”
    Get more information
    Journal Article